Saniona borrows USD 10m for clinical studies

The loan will be used to finance the clinical development of the biotech company's assets.
Rami Levin, President & Chief Executive Officer of Saniona | Photo: Saniona / PR
Rami Levin, President & Chief Executive Officer of Saniona | Photo: Saniona / PR
BY MIKKEL AABENHUS HEMMINGSEN, TRANSLATED BY CATHERINE BRETT

Biotech company Saniona has secured resources to continue the development of the company's assets as well as support general operations.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading